rs6674856

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001852.4(COL9A2):​c.1793-17T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0304 in 1,610,114 control chromosomes in the GnomAD database, including 1,937 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.070 ( 734 hom., cov: 32)
Exomes 𝑓: 0.026 ( 1203 hom. )

Consequence

COL9A2
NM_001852.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.529

Publications

4 publications found
Variant links:
Genes affected
COL9A2 (HGNC:2218): (collagen type IX alpha 2 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
COL9A2 Gene-Disease associations (from GenCC):
  • epiphyseal dysplasia, multiple, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome, type 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • multiple epiphyseal dysplasia due to collagen 9 anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Stickler syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-40301906-A-G is Benign according to our data. Variant chr1-40301906-A-G is described in ClinVar as Benign. ClinVar VariationId is 258378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL9A2NM_001852.4 linkc.1793-17T>C intron_variant Intron 30 of 31 ENST00000372748.8 NP_001843.1 Q14055

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL9A2ENST00000372748.8 linkc.1793-17T>C intron_variant Intron 30 of 31 1 NM_001852.4 ENSP00000361834.3 Q14055
COL9A2ENST00000482722.5 linkn.2096-17T>C intron_variant Intron 29 of 30 1
COL9A2ENST00000466267.1 linkn.758-17T>C intron_variant Intron 10 of 10 5

Frequencies

GnomAD3 genomes
AF:
0.0695
AC:
10579
AN:
152132
Hom.:
727
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.185
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0442
Gnomad ASJ
AF:
0.0409
Gnomad EAS
AF:
0.0262
Gnomad SAS
AF:
0.0342
Gnomad FIN
AF:
0.0230
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0215
Gnomad OTH
AF:
0.0454
GnomAD2 exomes
AF:
0.0405
AC:
9919
AN:
244810
AF XY:
0.0364
show subpopulations
Gnomad AFR exome
AF:
0.186
Gnomad AMR exome
AF:
0.0618
Gnomad ASJ exome
AF:
0.0410
Gnomad EAS exome
AF:
0.0226
Gnomad FIN exome
AF:
0.0243
Gnomad NFE exome
AF:
0.0210
Gnomad OTH exome
AF:
0.0282
GnomAD4 exome
AF:
0.0263
AC:
38390
AN:
1457864
Hom.:
1203
Cov.:
31
AF XY:
0.0262
AC XY:
19024
AN XY:
725182
show subpopulations
African (AFR)
AF:
0.198
AC:
6610
AN:
33318
American (AMR)
AF:
0.0589
AC:
2617
AN:
44424
Ashkenazi Jewish (ASJ)
AF:
0.0409
AC:
1066
AN:
26048
East Asian (EAS)
AF:
0.0330
AC:
1310
AN:
39642
South Asian (SAS)
AF:
0.0355
AC:
3040
AN:
85646
European-Finnish (FIN)
AF:
0.0250
AC:
1333
AN:
53280
Middle Eastern (MID)
AF:
0.0252
AC:
145
AN:
5764
European-Non Finnish (NFE)
AF:
0.0182
AC:
20241
AN:
1109510
Other (OTH)
AF:
0.0337
AC:
2028
AN:
60232
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1747
3494
5240
6987
8734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0697
AC:
10618
AN:
152250
Hom.:
734
Cov.:
32
AF XY:
0.0696
AC XY:
5185
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.185
AC:
7684
AN:
41518
American (AMR)
AF:
0.0441
AC:
675
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0409
AC:
142
AN:
3472
East Asian (EAS)
AF:
0.0262
AC:
136
AN:
5182
South Asian (SAS)
AF:
0.0340
AC:
164
AN:
4824
European-Finnish (FIN)
AF:
0.0230
AC:
244
AN:
10612
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0215
AC:
1463
AN:
68012
Other (OTH)
AF:
0.0482
AC:
102
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
487
974
1462
1949
2436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0519
Hom.:
75
Bravo
AF:
0.0760
Asia WGS
AF:
0.0660
AC:
228
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 10, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.17
DANN
Benign
0.57
PhyloP100
-0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6674856; hg19: chr1-40767578; COSMIC: COSV65622340; COSMIC: COSV65622340; API